No abstract available
MeSH terms
-
Benzamides
-
Drug Monitoring*
-
Humans
-
Imatinib Mesylate
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
-
Medication Adherence
-
Piperazines / pharmacokinetics*
-
Protein Kinase Inhibitors / pharmacokinetics*
-
Pyrimidines / pharmacokinetics*
-
Randomized Controlled Trials as Topic
-
Remission Induction
Substances
-
Benzamides
-
Piperazines
-
Protein Kinase Inhibitors
-
Pyrimidines
-
Imatinib Mesylate